Trial Profile
Brush-evoked allodynia in patients with peripheral neuropathy before and following intravenous infusion of ondansetron. A randomised, double-blind, placebo controlled, cross-over study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 14 Jun 2011 New trial record